Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1-10 of 40

Page
per page
  1. QS 11
    B7364 QS 11
    Summary: ARFGAP1 inhibitor,Wnt/beta-catenin pathway modulator
      Soluble in DMSO
  2. JW 55
    A4529 JW 55
    Summary: PARP domain inhibitor
      insoluble in H2O; ≥19.25 mg/mL
  3. KY 02111
    A8213 KY 02111
    Summary: WNT signaling inhibitor
      insoluble in H2O; ≥18.85 mg/mL
  4. ICG 001
    A8217 ICG 001
     1 Citation
    Summary: Wnt/β-catenin pathway inhibitor
      ≥27.43 mg/mL
  5. XAV-939
    A1877 XAV-939
     1 Citation
    Target: TNKS
    Summary: Tankyrase 1/2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
  6. CHIR-99021 (CT99021) HCl
    A8396 CHIR-99021 (CT99021) HCl
    Target: GSK-3
    Summary: GSK-3α/β inhibitor
      ≥25.1 mg/mL
  7. Tankyrase Inhibitors (TNKS) 22
    A8600 Tankyrase Inhibitors (TNKS) 22
    Summary: Tankyrase inhibitor
  8. Tankyrase Inhibitors (TNKS) 49
    A8601 Tankyrase Inhibitors (TNKS) 49
    Target: Tankyrases
    Summary: Tankyrase inhibitor
      ≥22.45 mg/mL
  9. Wnt-C59
    A8685 Wnt-C59
     2 Citation
    Target: PORCN
    Summary: PORCN inhibitor,highly potent and selective
      .95 mg/mL
      insoluble in H2O; ≥18
  10. IWP-L6
    B2305 IWP-L6
    Summary: Porcupine inhibitor,highy potent
      ≥22.45 mg/mL

Items 1-10 of 40

Page
per page